In early 2020, in response to the COVID-19 pandemic, the IPC Board of Directors issued a statement regarding its impact on patients with psoriasis and established a web-based psoriasis and COVID-19 resource center. The resource center includes videos on real-world experiences from physicians at the forefront of the pandemic, expert opinions on published manuscripts, links to treatment guidelines, and information on the PsoProtect and PsoProtectMe COVID-19 registries of which IPC is a global partner. Later in 2020, the IPC board issued a new statement regarding the impact of psoriasis therapy, particularly systemic treatment, on the effectiveness and safety of vaccines. The board will continue to monitor the pandemic's impact on psoriasis care and provide guidance statements for the community, when appropriate, and additional resources as needed.